Washington D.C. – Ralph Abraham, M.D., was sworn in today as Principal Deputy Director of the Centers for Disease Control and Prevention (CDC) by Health and Human Services Secretary Robert F. Kennedy, Jr., marking a significant moment for the agency as it refocuses on its core mission of infectious disease prevention. The swearing-in ceremony took place on December 15, 2025, and Dr. Abraham will officially initiate his duties at CDC headquarters in Atlanta on January 5, 2026. This appointment comes at a time of renewed emphasis on public health preparedness and a commitment to transparency within the CDC.
Dr. Abraham brings nearly three decades of medical experience to the role, most recently serving as Surgeon General of the state of Louisiana. His background as a practicing physician, coupled with his experience in public health leadership, positions him to address the complex challenges facing the nation’s health protection agency. The appointment of Dr. Abraham is part of a broader effort by Secretary Kennedy to realign the CDC with its primary function: safeguarding Americans from infectious diseases.
“The CDC’s foremost duty is to protect the American people from infectious disease,” Secretary Kennedy stated. “Dr. Abraham recognizes that responsibility. He brings the integrity, courage, and decades of medical experience required to restore the CDC’s standing as the world’s most trusted defender of public health.” This sentiment reflects a commitment to rebuilding public trust in the CDC, an institution that has faced scrutiny in recent years.
A Diverse Background in Medicine and Public Service
Dr. Abraham’s career path is notably diverse. He initially practiced as a veterinarian for ten years after graduating from the Louisiana State University School of Veterinary Medicine before earning his M.D. From the Louisiana State University School of Medicine. He then transitioned to family medicine, providing direct patient care. This blend of veterinary and human medicine offers a unique perspective on zoonotic diseases – those that can transmit from animals to humans – an increasingly vital area of public health concern.
Beyond his medical practice, Dr. Abraham also served as the U.S. Representative for Louisiana’s fifth congressional district from 2015 to 2021. During his time in Congress, he was involved in committees focused on armed services, agriculture, and science, space, and technology, providing him with a broad understanding of the factors influencing public health. His legislative experience could prove valuable in navigating the political landscape and advocating for the CDC’s needs.
As Louisiana’s Surgeon General, Dr. Abraham was responsible for shaping health policy, promoting disease prevention initiatives, and coordinating efforts across state agencies to improve health outcomes. He also participated in humanitarian missions in several countries, including Afghanistan, Haiti, Africa, and the Amazon rainforest, demonstrating a commitment to global health.
Transition at the CDC and a Focus on Transparency
Dr. Abraham’s arrival at the CDC follows a period of transition within the agency. Jim O’Neill recently stepped down as Acting CDC Director and Deputy Secretary, creating vacancies in the top two positions. According to CIDRAP, Dr. Abraham’s resignation took effect immediately, becoming the second senior official to exit the agency this month. Jay Bhattacharya, M.D., director of the National Institutes of Health, has been named interim CDC director.
Deputy Secretary O’Neill emphasized the CDC’s renewed focus, stating, “CDC has turned a corner and refocused on its core mission of defending America and the world against infectious disease. It is also advancing Secretary Kennedy’s mission to make America healthy again. I am delighted to have Dr. Abraham’s clinical and scientific expertise to accelerate radical transparency and make CDC the best it can be.” This commitment to “radical transparency” suggests a shift in the agency’s approach to communication and data sharing, potentially increasing public access to information about public health threats.
Dr. Abraham himself echoed this sentiment, saying, “I am honored to join Secretary Kennedy and Deputy Secretary O’Neill in their mission to reform the CDC. By putting sound science first — and checking our ideologies at the door — People can make the CDC a model for the world in infectious disease tracking, prevention, and treatment.” This statement underscores the importance of evidence-based decision-making and a commitment to objectivity in public health policy.
Looking Ahead
The appointment of Dr. Abraham signals a new chapter for the CDC, one characterized by a renewed focus on its core mission and a commitment to transparency. As the agency navigates ongoing and emerging infectious disease threats, Dr. Abraham’s experience and leadership will be crucial. The CDC will continue to monitor and respond to public health challenges, working to protect the health and well-being of the American people.
The next key development will be the ongoing perform of the CDC under Dr. Abraham’s leadership, particularly as the agency addresses current concerns such as measles outbreaks and prepares for potential future pandemics. Updates on the CDC’s initiatives and priorities can be found on the agency’s official website: www.cdc.gov.
What are your thoughts on the new leadership at the CDC? Share your comments below, and please share this article with your network.
